ASCO: Pembrolizumab superior for initial Tx of advanced NSCLC

(HealthDay)—For patients with programmed death ligand 1 (PD-L1)-expressing locally advanced or metastatic non-small-cell lung cancer (NSCLC), pembrolizumab is associated with better overall survival t

Updated on: March 30,2024

ASCO: Pembrolizumab superior for initial Tx of advanced NSCLC

(HealthDay)—For patients with programmed death ligand 1 (PD-L1)-expressing locally advanced or metastatic non-small-cell lung cancer (NSCLC), pembrolizumab is associated with better overall survival t

Updated on:March 30,2024

AI tool 'DeepHRD' accelerates cancer treatment decisions

byUniversity of California - San DiegoFirst author Erik Bergstrom showcasing a biopsy analysis completed with DeepHRD, a new artificial intelligence tool that can detect clinically actionable ge

Updated on: August 28,2024

AI tool 'DeepHRD' accelerates cancer treatment decisions

byUniversity of California - San DiegoFirst author Erik Bergstrom showcasing a biopsy analysis completed with DeepHRD, a new artificial intelligence tool that can detect clinically actionable ge

Updated on:August 28,2024

Epigenetic mechanism associated with clinical outcome and therapeutic vulnerability in liver cancer

by Josep Carreras Leukaemia Research InstituteNSUN7 epigenetic loss occurs in human primary HCC tumors in association with worse clinical outcome. (A) Percentage of NSUN7 methylation in the TCGA

Updated on: February 18,2024

Epigenetic mechanism associated with clinical outcome and therapeutic vulnerability in liver cancer

by Josep Carreras Leukaemia Research InstituteNSUN7 epigenetic loss occurs in human primary HCC tumors in association with worse clinical outcome. (A) Percentage of NSUN7 methylation in the TCGA

Updated on:February 18,2024

Intraventricular immunovirotherapy: A translational step forward

by Impact JournalsPutative mechanisms of toxicity. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28343A new research perspective titled "Intraventricular immunovirotherapy; a tran

Updated on: January 02,2024

Intraventricular immunovirotherapy: A translational step forward

by Impact JournalsPutative mechanisms of toxicity. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28343A new research perspective titled "Intraventricular immunovirotherapy; a tran

Updated on:January 02,2024

A new drug prevents epithelial-mesenchymal transition, metastasis and resistance to anti-cancer therapy

by Université libre de BruxellesTargeting netrin-1 reduces metastasis and sensitizes tumor cells to chemotherapy in skin SCC.a, Dot plot showing the number of spontaneous lung metastases in

Updated on: January 30,2024

A new drug prevents epithelial-mesenchymal transition, metastasis and resistance to anti-cancer therapy

by Université libre de BruxellesTargeting netrin-1 reduces metastasis and sensitizes tumor cells to chemotherapy in skin SCC.a, Dot plot showing the number of spontaneous lung metastases in

Updated on:January 30,2024

Study successfully mimics complex neuroblastoma vasculature on a chip to explore treatments

by Institute for Bioengineering of CataloniaGraphical abstract. Credit:Cancers(2024). DOI: 10.3390/cancers16051060Neuroblastoma, one of the most common childhood cancers, is classified as

Updated on: March 30,2024

Study successfully mimics complex neuroblastoma vasculature on a chip to explore treatments

by Institute for Bioengineering of CataloniaGraphical abstract. Credit:Cancers(2024). DOI: 10.3390/cancers16051060Neuroblastoma, one of the most common childhood cancers, is classified as

Updated on:March 30,2024

Expanding LDCT eligibility guidelines would increase number of women and Blacks who benefit from screening

by International Association for the Study of Lung CancerCredit: CC0 Public DomainExpanding the eligibility criteria for low-dose CT (LDCT) screening for lung cancer can increase the number of women a

Updated on: December 28,2023

Expanding LDCT eligibility guidelines would increase number of women and Blacks who benefit from screening

by International Association for the Study of Lung CancerCredit: CC0 Public DomainExpanding the eligibility criteria for low-dose CT (LDCT) screening for lung cancer can increase the number of women a

Updated on:December 28,2023

Study finds 'startling' inequities in end-of-life opioid treatment

byHarvard UniversityCredit: Unsplash/CC0 Public DomainOlder Black and Hispanic patients with advanced cancer are less likely than white patients to receive opioid medications for pain relief in

Updated on: January 23,2024

Study finds 'startling' inequities in end-of-life opioid treatment

byHarvard UniversityCredit: Unsplash/CC0 Public DomainOlder Black and Hispanic patients with advanced cancer are less likely than white patients to receive opioid medications for pain relief in

Updated on:January 23,2024

Two genomic studies could yield more effective, less toxic immunotherapies

by Institut CurieTE-Exon splicing junctions can help differentiate tumors from healthy tissue. Credit: Verge Scientific Communications / Antonela Merlotti / Marianne Burbage / Benjamin SadaccaMnemo Th

Updated on: December 28,2023

Two genomic studies could yield more effective, less toxic immunotherapies

by Institut CurieTE-Exon splicing junctions can help differentiate tumors from healthy tissue. Credit: Verge Scientific Communications / Antonela Merlotti / Marianne Burbage / Benjamin SadaccaMnemo Th

Updated on:December 28,2023

Novel, non-invasive method to predict and reduce the relapse of childhood cancers

by National University of SingaporeNeuroblastoma CTCs expressing characteristic markers are isolated using cell size-based separation. (A) Schema of experimental design and 3 serial timepoints wh

Updated on: February 03,2024

Novel, non-invasive method to predict and reduce the relapse of childhood cancers

by National University of SingaporeNeuroblastoma CTCs expressing characteristic markers are isolated using cell size-based separation. (A) Schema of experimental design and 3 serial timepoints wh

Updated on:February 03,2024

Researchers discover a new cancer-driving mutation in 'dark matter' of the cancer genome

by Ontario Institute for Cancer ResearchCredit: CC0 Public DomainAn Ontario-led research group has discovered a novel cancer-driving mutation in the vast non-coding regions of the human cancer genome,

Updated on: June 04,2024

Researchers discover a new cancer-driving mutation in 'dark matter' of the cancer genome

by Ontario Institute for Cancer ResearchCredit: CC0 Public DomainAn Ontario-led research group has discovered a novel cancer-driving mutation in the vast non-coding regions of the human cancer genome,

Updated on:June 04,2024

'Promising' antibody therapy extends survival in mice with pancreatic cancer

by Pancreatic Cancer Research FundAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainScientists have found a way to target and knock out a singl

Updated on: May 07,2024

'Promising' antibody therapy extends survival in mice with pancreatic cancer

by Pancreatic Cancer Research FundAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainScientists have found a way to target and knock out a singl

Updated on:May 07,2024